Péter Klivènyi

10.6k total citations · 2 hit papers
214 papers, 7.2k citations indexed

About

Péter Klivènyi is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Péter Klivènyi has authored 214 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Neurology, 68 papers in Molecular Biology and 59 papers in Cellular and Molecular Neuroscience. Recurrent topics in Péter Klivènyi's work include Parkinson's Disease Mechanisms and Treatments (40 papers), Genetic Neurodegenerative Diseases (39 papers) and Mitochondrial Function and Pathology (33 papers). Péter Klivènyi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (40 papers), Genetic Neurodegenerative Diseases (39 papers) and Mitochondrial Function and Pathology (33 papers). Péter Klivènyi collaborates with scholars based in Hungary, United States and Austria. Péter Klivènyi's co-authors include László Vécsei, Robert J. Ferrante, Ole A. Andreassen, Dénes Zádori, M. Flint Beal, Gerald Mueller, M. Flint Beal, József Toldi, Alpaslan Dedeoglu and Lichuan Yang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Péter Klivènyi

199 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

2000 980 citations Péter Klivènyi, Ole A. Andreassen et al. profile →
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis

1999 554 citations Péter Klivènyi, Robert J. Ferrante et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Péter Klivènyi Hungary	40	3.1k	2.3k	1.9k	1.0k	866	214	7.2k
Alessandro Usiello Italy	49	3.2k 1.0×	3.8k 1.7×	1.2k 0.6×	889 0.9×	536 0.6×	145	7.3k
Dorit Ben‐Shachar Israel	47	2.6k 0.8×	2.0k 0.9×	2.0k 1.0×	1.1k 1.0×	826 1.0×	102	7.5k
Bastian Hengerer Germany	39	2.5k 0.8×	3.7k 1.6×	1.9k 1.0×	1.4k 1.4×	464 0.5×	107	7.2k
Giambattista Bonanno Italy	45	3.1k 1.0×	3.4k 1.5×	836 0.4×	685 0.7×	489 0.6×	204	6.8k
Ana M. Sebastião Portugal	58	3.4k 1.1×	4.9k 2.2×	957 0.5×	1.1k 1.1×	573 0.7×	241	10.2k
Fabrizio Gardoni Italy	53	3.0k 1.0×	4.7k 2.1×	1.6k 0.8×	2.0k 1.9×	516 0.6×	150	8.6k
William O. Whetsell United States	36	2.5k 0.8×	3.1k 1.4×	1.2k 0.6×	867 0.8×	1.1k 1.3×	105	6.5k
Heii Arai Japan	42	1.9k 0.6×	1.7k 0.8×	1.2k 0.6×	1.9k 1.8×	696 0.8×	268	6.5k
Barbara Monti Italy	32	2.9k 0.9×	2.1k 0.9×	989 0.5×	1.5k 1.4×	599 0.7×	95	8.4k
John D. Elsworth United States	52	2.9k 0.9×	4.3k 1.9×	1.6k 0.8×	1.4k 1.4×	368 0.4×	155	9.1k

Countries citing papers authored by Péter Klivènyi

Since Specialization

Citations

This map shows the geographic impact of Péter Klivènyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Klivènyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Klivènyi more than expected).

Fields of papers citing papers by Péter Klivènyi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Klivènyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Klivènyi. The network helps show where Péter Klivènyi may publish in the future.

Co-authorship network of co-authors of Péter Klivènyi

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Klivènyi. A scholar is included among the top collaborators of Péter Klivènyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Klivènyi. Péter Klivènyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Polyák, Helga, et al.. (2025). Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model. International Journal of Molecular Sciences. 26(3). 976–976. 1 indexed citations

Szpisjak, László, et al.. (2024). The Application of Goal Attainment Scaling in Cervical Dystonia – An Exploratory Observational Pilot Study. Movement Disorders Clinical Practice. 11(8). 1013–1017.

Engelhardt, József I., et al.. (2024). Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations. BMC Medical Genomics. 17(1). 30–30. 8 indexed citations

Kalmár, Tibor, et al.. (2023). Novel heterozygous STUB1 gene mutation causes SCA48 in a Hungarian patient. Ideggyógyászati Szemle. 76(1-2). 63–72. 1 indexed citations

Boros, Fanni Annamária, László Szpisjak, Dénes Zádori, et al.. (2023). Spinocerebellar Ataxia in a Hungarian Female Patient with a Novel Variant of Unknown Significance in the CCDC88C Gene. International Journal of Molecular Sciences. 24(3). 2617–2617. 2 indexed citations

Polyák, Helga, Cecília Rajda, Gábor Veres, et al.. (2023). The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis. Biomedicines. 11(3). 945–945. 33 indexed citations

Sperling, Michael R., Jacqueline A. French, Patricia Dugan, et al.. (2023). Prediction tools and risk stratification in epilepsy surgery. Epilepsia. 65(2). 414–421. 3 indexed citations

Molnár, Viktor, András Gézsi, Zoltán Grosz, et al.. (2022). Genetic landscape of early-onset dementia in Hungary. Neurological Sciences. 43(9). 5289–5300. 5 indexed citations

Zádori, Dénes, Anikó Újfalusi, László Szpisjak, et al.. (2021). Hereditary and non-hereditary etiologies associated with extensive brain calcification: case series. Metabolic Brain Disease. 36(7). 2131–2139. 1 indexed citations

10.

Maszlag-Török, Rita, Fanni Annamária Boros, László Vécsei, & Péter Klivènyi. (2021). Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson’s disease. Scientific Reports. 11(1). 10677–10677. 23 indexed citations

11.

Grosz, Zoltán, Michael Gonzalez, Anikó Gál, et al.. (2016). Genetic background of the hereditary spastic paraplegia phenotypes in Hungary — An analysis of 58 probands. Journal of the Neurological Sciences. 364. 116–121. 24 indexed citations

12.

Zádori, Dénes, Gábor Veres, Levente Szalárdy, et al.. (2016). Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012–2015). Expert Opinion on Therapeutic Patents. 26(7). 815–832. 13 indexed citations

13.

Szpisjak, László, Nóra Zsindely, József I. Engelhardt, et al.. (2016). Novel AARS2 gene mutation producing leukodystrophy: a case report. Journal of Human Genetics. 62(2). 329–333. 25 indexed citations

14.

Zádori, Dénes, et al.. (2013). Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.. PubMed. 66(11-12). 407–14. 2 indexed citations

15.

Bereznai, Benjámin, Annamária Takáts, Péter Klivènyi, et al.. (2012). [The absence of the common LRRK2 G2019S mutation in 120 young onset Hungarian Parkinon's disease patients].. PubMed. 65(7-8). 239–42. 2 indexed citations

16.

Zádori, Dénes, Gábor Nyíri, András Szőnyi, et al.. (2010). Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease. Journal of Neural Transmission. 118(6). 865–875. 86 indexed citations

17.

Klivènyi, Péter, et al.. (2006). Behaviour changes in a transgenic model of Huntington's disease. Behavioural Brain Research. 169(1). 137–141. 21 indexed citations

18.

Klivènyi, Péter, Noel Y. Calingasan, Anatoly A. Starkov, et al.. (2004). Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiology of Disease. 15(3). 610–617. 47 indexed citations

19.

Barberi, Tiziano, Péter Klivènyi, Noel Y. Calingasan, et al.. (2003). Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nature Biotechnology. 21(10). 1200–1207. 487 indexed citations

20.

Andreassen, Ole A., Robert J. Ferrante, Péter Klivènyi, et al.. (2001). Transgenic ALS Mice Show Increased Vulnerability to the Mitochondrial Toxins MPTP and 3-Nitropropionic Acid. Experimental Neurology. 168(2). 356–363. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact